| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/21/2013 | WO2013025442A2 Concentrated felbamate formulations for parenteral administration |
| 02/21/2013 | WO2013025425A1 Soluble guanylate cyclase activators |
| 02/21/2013 | WO2013025042A2 Composition including stem cell-derived microvesicles for promoting neurogenesis |
| 02/21/2013 | WO2013024898A1 Heterocyclic derivative and pharmaceutical drug |
| 02/21/2013 | WO2013024474A1 Polymorphs of preladenant |
| 02/21/2013 | WO2013024312A1 A pharmaceutical composition for the treatment of stem cells |
| 02/21/2013 | WO2013024168A1 Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease |
| 02/21/2013 | WO2013024028A1 Compounds and compositions for treating proteinopathies |
| 02/21/2013 | WO2013023852A1 Agonistic autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in alzheimer's and vascular dementia |
| 02/21/2013 | WO2013023439A1 Salt and polymorph of pyrazolopyrimidinone compound and drug composition, preparation method and use thereof |
| 02/21/2013 | WO2013000895A9 Dha and epa in the reduction of oxidative stress |
| 02/21/2013 | WO2012170839A3 Treatment of neuroinflammatory disease with selective cox1 inhibitors |
| 02/21/2013 | WO2012158624A3 Inhibitors of mitochondrial fission and methods of use thereof |
| 02/21/2013 | WO2012038565A3 PROTEINS OF THE CRY FAMILY AS MARKERS FOR DETERMINING THE RISK OF DEVELOPING AN α-SYNUCLEINOPATHY OR DETERMINING SAID DISEASE |
| 02/21/2013 | WO2012009576A9 Prevention and treatment of pain using monoclonal antibodies and antibody fragments to lysophosphatidic acid |
| 02/21/2013 | WO2011101069A3 1, 8 -naphthyridines as kinase inhibitors |
| 02/21/2013 | US20130046275 Material and method for treating internal cavities |
| 02/21/2013 | US20130046023 Pharmaceutical composition containing glur2-lacking ampar antagonist for preventing or treating psychiatric illnesses |
| 02/21/2013 | US20130046020 Eicosapentaenoic acid concentrate |
| 02/21/2013 | US20130046015 Therapeutic Inhibition of Granulocyte Function in Demyelinating Disease |
| 02/21/2013 | US20130046008 Selective reduction of allelic variants |
| 02/21/2013 | US20130046007 Selective reduction of allelic variants |
| 02/21/2013 | US20130046005 Treatment of immune disorders using kainate receptor antagonists |
| 02/21/2013 | US20130046004 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/21/2013 | US20130046003 Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating retinal diseases |
| 02/21/2013 | US20130046001 Pharmaceutical composition for inhibiting apoptosis of neuron or neurodegeneration |
| 02/21/2013 | US20130046000 Compounds for suppressing a peripheral nerve disorder induced by an anti-cancer agent |
| 02/21/2013 | US20130045998 Process for preparing rufinamide intermediate |
| 02/21/2013 | US20130045997 Pirfenidone therapy and inducers of of cytochrome p450 |
| 02/21/2013 | US20130045991 Neuroprotective modulation of nmda receptor subtype activities |
| 02/21/2013 | US20130045987 Novel methods of use of tetrahydroberberine (thb) |
| 02/21/2013 | US20130045986 Novel compounds as modulators of gpr-119 |
| 02/21/2013 | US20130045981 Aripiprazole complex formulation and method |
| 02/21/2013 | US20130045979 Method of treating major depressive disorder |
| 02/21/2013 | US20130045978 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 02/21/2013 | US20130045977 TGF-beta SIGNAL TRANSDUCTION INHIBITOR |
| 02/21/2013 | US20130045975 Bicyclic heteroaryl inhibitors of pde4 |
| 02/21/2013 | US20130045973 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/21/2013 | US20130045964 Mandelamide heterocyclic compounds |
| 02/21/2013 | US20130045963 Cyclohexyl Azetidine Derivatives as JAK Inhibitors |
| 02/21/2013 | US20130045960 Abuse-Deterrent Pharmaceutical Compositions of Opiods and Other Drugs |
| 02/21/2013 | US20130045948 Azocyclic inhibitors of fatty acid amide hydrolase |
| 02/21/2013 | US20130045942 N6-substituted adenosine derivatives and n6-substituted adenine derivatives and uses thereof |
| 02/21/2013 | US20130045934 Extraction method using ultra fine bubbles and liquid extracts obtained thereof |
| 02/21/2013 | US20130045924 Methods of reducing hypoxic stress in a mammal by administering soluble p-selectin |
| 02/21/2013 | US20130045922 Pro-angiogenic fragments of prominin-1 and uses thereof |
| 02/21/2013 | US20130045919 Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents |
| 02/21/2013 | US20130045914 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 02/21/2013 | US20130045289 Composition for promoting the activity of peroxisome proliferator-activated receptor-delta |
| 02/21/2013 | US20130045287 Treatment for Concussion using Gallium Compounds |
| 02/21/2013 | US20130045279 Analgesic and anti-inflammatory composition |
| 02/21/2013 | US20130045276 Sustained release aminopyridine composition |
| 02/21/2013 | US20130045268 Abuse-resistant mucoadhesive devices for delivery of buprenorphine |
| 02/21/2013 | US20130045262 Sedative for external use, and sedative sheet, and textile, clothing, wall material, and hyperthermia equipment, brain vitalization sheet, brain vitalization small pillow |
| 02/21/2013 | US20130045253 Oral antidepressant formulation with reduced excipient load |
| 02/21/2013 | US20130045250 Suspension and cake composition containing carbostyryl derivative and silicone oil and/or silicone oil derivative |
| 02/21/2013 | US20130045247 Fatty acid conjugates of quetiapine, process for making and using the same |
| 02/21/2013 | US20130045219 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof |
| 02/21/2013 | US20130045218 Fc receptor binding proteins |
| 02/21/2013 | US20130045216 Method for Treating Amyloid Disease |
| 02/21/2013 | US20130045213 Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity |
| 02/21/2013 | US20130045189 Methods of treating stroke through administration of ctx0e03 cells |
| 02/21/2013 | US20130045187 Methods and compositions of producing patient-specific multipotent neuronal stem cells |
| 02/21/2013 | US20130045186 Method of Detecting and/or Identifying Adeno-Associated Virus (AAV) Sequences and Isolating Novel Sequences Identified Thereby |
| 02/21/2013 | US20130045183 Boswellia oil, its fractions and compositions for enhancing brain function |
| 02/21/2013 | US20130045172 USE OF CIS-EPOXYEICOSATRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO TREAT CONDITIONS MEDIATED BY PBR, CB2, and NK2 RECEPTORS |
| 02/21/2013 | US20130045165 4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators |
| 02/21/2013 | US20130045164 Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 02/21/2013 | US20130045160 Magnetic Nano-Composite for Contrast Agent, Intelligent Contrast Agent, Drug Delivery Agent for Simultaneous Diagnosis and Treatment, and Separation Agent for Target Substance |
| 02/21/2013 | CA2846213A1 Methods for ameliorating symptoms or conditions caused by stress |
| 02/21/2013 | CA2845634A1 Abuse-resistant mucoadhesive devices for delivery of buprenorphine |
| 02/21/2013 | CA2845250A1 Salt and polymorph of pyrazolopyrimidinone compound, and pharmaceutical composition containing the same, preparation method and use thereof |
| 02/21/2013 | CA2844907A1 Concentrated felbamate formulations for parenteral administration |
| 02/21/2013 | CA2844794A1 Heterocyclic derivative and pharmaceutical |
| 02/21/2013 | CA2841037A1 Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease |
| 02/20/2013 | EP2559694A2 Azaindoles useful as inhibitors of Janus kinases |
| 02/20/2013 | EP2559693A1 Polycyclic compound |
| 02/20/2013 | EP2559685A1 Fentanyl derivatives as pH-dependent opioid receptor agonists |
| 02/20/2013 | EP2559435A1 Rotigotine in the treatment of hemispatial neglect, stroke and deficits following stroke |
| 02/20/2013 | EP2558503A1 Compositions and methods for brain delivery of analgesic peptides |
| 02/20/2013 | EP2558467A1 Aryl - /heteroaryl - cyclohexenyl - tetraazabenzo [e]azulenes as vasopressin antagonists |
| 02/20/2013 | EP2558457A1 Arylethynyl derivatives |
| 02/20/2013 | EP2558455A1 Synthesis of duloxetine and/or pharmaceutically acceptable salts thereof |
| 02/20/2013 | EP2558446A1 Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 02/20/2013 | EP2558440A1 Process for the production of polymorph form i of agomelatine |
| 02/20/2013 | EP2558437A2 Methods for producing viloxazine salts and novel polymorphs thereof |
| 02/20/2013 | EP2558089A1 Statins for the prevention or treatment of drug addictions |
| 02/20/2013 | EP1934212B1 9-azabicyclo [3 . 3 . 1]nonane derivatives as monoamine reuptake inhibitors |
| 02/20/2013 | CN102939287A 雌激素受体调节剂及其用途 Estrogen receptor modulators and their use |
| 02/20/2013 | CN102939282A Novel compounds for the treatment of diseases associated with amyloid or amyloid-like proteins |
| 02/20/2013 | CN102939087A Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |
| 02/20/2013 | CN102939084A Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue |
| 02/20/2013 | CN102936545A Albizia julibrissin health-care wine capable of resolving depression for tranquilization |
| 02/20/2013 | CN102936291A Method for preparing selenylation poly mannuronic acid and application of selenylation poly mannuronic acid |
| 02/20/2013 | CN102936287A Antibody capable of binding specifically to A beta-oligomer, and use thereof |
| 02/20/2013 | CN102936252A Sesterterpine compounds, and preparation method and application thereof |
| 02/20/2013 | CN102936250A 稠合双环mTOR抑制剂 Fused bicyclic inhibitors of mTOR |
| 02/20/2013 | CN102936244A Tacrine-phenothiazine isodiad compound and preparation method thereof |
| 02/20/2013 | CN102936233A New crystal form of 1-[di(4- fluorophenyl)methyl]-4-(2,3,4-trimethyl phenyl) piperazine dihydrochloride |
| 02/20/2013 | CN102935220A Medicine for improving sub-health condition of human body |